RERG is frequently silenced by promoter CpG methylation in nasopharyngeal carcinoma and inhibits the metastatic process and angiogenesis of NPC by mediating ERK/NF-κB signaling pathway [50]. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.